Skip to main content
CABR logo

CABR · Caring Brands, Inc. · Financials

Track CABR — free
$1.40 +0.05 (+3.70%)
Market Cap
$12.23M
Shares
10.37M

Income-statement, balance-sheet and cash-flow figures from SEC filings, plus a debt profile anchored in the latest 10-K and updated by each 10-Q and debt exhibit.

Revenue
$4215
FY2025
Net Income
-$6.28M -313.7%
FY2025 Net Income FY2024–FY2025
Gross Margin
55.56%
FY2025
Operating Margin
-140807.24%
FY2025
Diluted EPS
-$0.46
FY2025
Operating Cash Flow
-$1.69M
FY2025

Chart any reported metric, KPI or segment over time — the full statement history lives here

Line Item TTM FY2025 FY2024
$4215
$19.17K
$1873
$2342
55.56%
$0 $39.56K
$931.28K
$210.93K $147.69K
$150K $300K $150K
$300K
$5.94M
-$7.1M -$5.94M
-140807.24%
-$5.64M
$305.77K $19.17K
-$343.17K
$0 $0
-$7.73M -$6.28M -$1.52M
-148948.78%
USD/shares -$0.74 -$0.46
USD/shares -$0.74 -$0.46
shares 13.57M
shares 13.57M
Italic rows are computed from reported lines — open a row's info icon for its formula. Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing. TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest.

Debt Profile

Annual debt figures are established from 10-K filings and updated by subsequent 10-Q and 8-K disclosures. Instrument balances are not summed into a company total unless the filing itself reports that total.

Debt data is being processed. Please check back later.

Price & Valuation

Multiples computed on the strict TTM/EV methodology — today's snapshot against peers, and each ratio recomputed as of past filing dates.

Valuation

EV/Revenue
2,397.13×
Peer median 0.71×
EV/EBIT
P/E (TTM)

Peer medians compare against the 34 similar-size Drug Manufacturers - Specialty & Generic companies (of 100 listed).

Valuation over time computed as of each quarter's filing date

Key facts CIK 2020737 CUSIP 14216J109 Visit website Investor relations